SyntheX
Latest round
- Seed
Last raised
- Dec 2023
Total raised
- $11M
Investors
- 5
About SyntheX
SyntheX, Inc.SyntheX, Inc. specializes in advanced drug discovery solutions, notably through its ToR FLEx platform.SyntheX specializes in advanced drug discovery solutions, primarily through its innovative ToR FLEx platform. This technology enables the engineering of cells to conduct functional selection of compounds that can modulate challenging protein targets, thereby unveiling novel mechanisms of action. The company's core offerings focus on overcoming limitations in traditional pharmacological approaches, particularly for high-potential drug targets that are often deemed inaccessible. End users include pharmaceutical companies and research institutions looking to expand their drug discovery capabilities into previously unreachable areas of the proteome.SyntheX's revenue model encompasses partnerships and collaborations with pharmaceutical and biotech firms, facilitating the discovery of new drug compounds. The company engages in B2B transactions, offering access to its ToR FLEx platform to external partners who seek to develop targeted therapies. Through these collaborations, SyntheX may implement contractual agreements that outline specific milestones and deliverables tied to the drug discovery process. Revenue may be generated through licensing deals or by providing access to proprietary technologies, with pricing structures potentially reflecting the complexity and scope of the projects undertaken.In April 2017, SyntheX, Inc. The company plans to design and launch new products aimed at enhancing its capabilities in drug discovery, although specific release dates have not been disclosed. Additionally, SyntheX is targeting expansion into new markets, particularly in Europe and Asia, to establish partnerships with local pharmaceutical companies and research institutions, enhancing its global footprint in the biotech industry.
Who invested in SyntheX
5 investors across 3 rounds
See all investors in SyntheX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SyntheX
Who invested in SyntheX?
SyntheX has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SyntheX raised?
SyntheX has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SyntheX last raise money?
SyntheX's most recent round on record is a Seed, in Dec 2023.
What does SyntheX do?
SyntheX is a biotechnology company.
Where is SyntheX headquartered?
SyntheX is headquartered in San Francisco, US.
Which VCs invest in companies like SyntheX?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SyntheX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like SyntheX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.